Autopsy report · NCT06606327

Diazoxide Suppression Test P&F Study

“Reprioritization of research efforts”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year 8 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Columbia University

Sponsor type

University, hospital or other

Conditions

Insulin Resistance; Hyperinsulinemia; Obesity

Interventions

Diazoxide, 3 mg/kg per dose

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Effect of NMBA on Surgical Conditions in THR
  “refocusing of research priorities” (67% match in meaning)
• Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes
  “Due to the insufficient accrual rate and strategic reasons to focus our efforts on higher impact research projects.” (57% match in meaning)
• Contrast-enhanced Ultrasound Versus CT Scan for Kidney Stone Patient Management
  “The research team submitted grants over the course of several years to gain funds to support this research but were unsuccessful in securing the funds. The research team will now focus on other funded studies.” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.